The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Open accessAbstract
Here we aim to provide updated guidance and standards for the indication, acquisition, and interpretation of PSMA PET/CT for prostate cancer imaging. Procedures and characteristics are reported for a variety of available PSMA small radioligands. Different scenarios for the clinical use of PSMA-ligand PET/CT are discussed. This document provides clinicians and technicians with the best available evidence, to support the implementation of PSMA PET/CT imaging in research and routine practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
Self-citationLutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Sartor, O., de Bono, J., Chi, K. N., Fizazi, K., Herrmann, K., Rahbar, K., Tagawa, S. T., Nordquist, L. T., Vaishampayan, N., El-Haddad, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107322 · Cited by 2,864
Self-citationMottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Self-citationRoach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
Hofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30314-7 · Cited by 2,040
Scher, H. I., Morris, M. J., Stadler, W. M., Higano, C., Basch, E., Fizazi, K., Antonarakis, E. S., Beer, T. M., Carducci, M. A., Chi, K. N., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.2702 · Cited by 1,654
(1997) · PubMed · Cited by 1,541
Hofman, M. S., Emmett, L., Sandhu, S., Iravani, A., Joshua, A. M., Goh, J. C., Pattison, D. A., Tan, T. H., Kirkwood, I. D., Ng, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00237-3 · Cited by 1,170
Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.046 · Cited by 1,079
Self-citationEiber, M., Maurer, T., Souvatzoglou, M., Beer, A. J., Ruffani, A., Haller, B., Graner, F.-P., Kübler, H., Haberhorn, U., Eisenhut, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154153 · Cited by 994
Self-citationProstate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Parker, C., Castro, E., Fizazi, K., Heidenreich, A., Ost, P., Procopio, G., Tombal, B., & Gillessen, S. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.011 · Cited by 977
Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2298-2 · Cited by 915
Self-citationTumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Ghosh, A., & Heston, W. D. W. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 878
Cookson, M. S., Aus, G., Burnett, A. L., Canby-Hagino, E. D., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., Goldenberg, S. L., Hernandez, J., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.10.097 · Cited by 844
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Eder, M., Schäfer, M., Bauder-Wüst, U., Hull, W.-E., Wängler, C., Mier, W., Haberkorn, U., & Eisenhut, M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200279b · Cited by 843
Self-citationRahbar, K., Ahmadzadehfar, H., Kratochwil, C., Haberkorn, U., Schäfers, M., Essler, M., Baum, R. P., Kulkarni, H. R., Schmidt, M., Drzezga, A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183194 · Cited by 832
Self-citationChang, S. S., Reuter, V. E., Heston, W. D. W., Bander, N. H., Grauer, L. S., & Gaudin, P. B. (1999) · PubMed · Cited by 825
Maurer, T., Gschwend, J. E., Rauscher, I., Souvatzoglou, M., Haller, B., Weirich, G., Wester, H.-J., Heck, M., Kübler, H., Beer, A. J., et al. (2016) · Journal of Urology · doi:10.1016/j.juro.2015.12.025 · Cited by 779
Self-citationFendler, W. P., Calais, J., Eiber, M., Flavell, R. R., Mishoe, A., Feng, F. Y., Nguyen, H. G., Reiter, R. E., Rettig, M. B., Okamoto, S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0096 · Cited by 779
Self-citation68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Ceci, F., Cho, S., Giesel, F., Haberkorn, U., Hope, T. A., Kopka, K., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3670-z · Cited by 750
Self-citationBostwick, D. G., Pacelli, A., Blute, M., Roche, P., & Murphy, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2256::aid-cncr22>3.0.co;2-s · Cited by 698
Eiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
Self-citationProstate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Horwich, A., Parker, C., Bangma, C., & Kataja, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq174 · Cited by 600
Giesel, F. L., Hadaschik, B., Cardinale, J., Radtke, J., Vinsensia, M., Lehnert, W., Kesch, C., Tolstov, Y., Singer, S., Grabe, N., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3573-4 · Cited by 592
Self-citationMorigi, J. J., Stricker, P. D., van Leeuwen, P. J., Tang, R., Ho, B., Nguyen, Q., Hruby, G., Fogarty, G., Jagavkar, R., Kneebone, A., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160382 · Cited by 571
Self-citationSimultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
Eiber, M., Weirich, G., Holzapfel, K., Souvatzoglou, M., Haller, B., Rauscher, I., Beer, A. J., Wester, H.-J., Gschwend, J., Schwaiger, M., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.12.053 · Cited by 568
Self-citationWeineisen, M., Schottelius, M., Simecek, J., Baum, R. P., Yildiz, A., Beykan, S., Kulkarni, H. R., Lassmann, M., Klette, I., Eiber, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158550 · Cited by 532
Self-citationNCCN Guidelines Insights: Prostate Cancer, Version 1.2021: Featured Updates to the NCCN Guidelines
Schaeffer, E., Srinivas, S., Antonarakis, E. S., Armstrong, A. J., Bekelman, J. E., Cheng, H., D’Amico, A. V., Davis, B. J., Desai, N., Dorff, T., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0008 · Cited by 525
Ross, J. S., Sheehan, C. E., Fisher, H. A. �., Kaufman, R. P., Kaur, P., Gray, K., Webb, I. J., Gray, G. S., Mosher, R. E., & Kallakury, B. (2003) · PubMed · Cited by 513
Calais, J., Ceci, F., Eiber, M., Hope, T. A., Hofman, M. S., Rischpler, C., Bach-Gansmo, T., Nanni, C., Savir-Baruch, B., Elashoff, D., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30415-2 · Cited by 476
Self-citationProstate-specific membrane antigen is produced in tumor-associated neovasculature.
Chang, S. S., O’Keefe, D. S., Bacich, D. J., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (1999) · PubMed · Cited by 471
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
Paschalis, A., Sheehan, B., Riisnaes, R., Rodrigues, D. N., Gurel, B., Bertan, C., Ferreira, A., Lambros, M. B. K., Seed, G., Yuan, W., et al. (2019) · European Urology · doi:10.1016/j.eururo.2019.06.030 · Cited by 455
Szabo, Z., Mena, E., Rowe, S. P., Plyku, D., Nidal, R., Eisenberger, M. A., Antonarakis, E. S., Fan, H., Dannals, R. F., Chen, Y., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0850-8 · Cited by 443
Self-citationEmmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M. J., Rasiah, K., Pattison, D. A., Yaxley, J., Thomas, P., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.08.002 · Cited by 430
Budäus, L., Leyh-Bannurah, S.-R., Salomon, G., Michl, U., Heinzer, H., Huland, H., Graefen, M., Steuber, T., & Rosenbaum, C. (2016) · European Urology · doi:10.1016/j.eururo.2015.06.010 · Cited by 429
Afshar-Oromieh, A., Hetzheim, H., Kratochwil, C., Benesova, M., Eder, M., Neels, O. C., Eisenhut, M., Kübler, W., Holland-Letz, T., Giesel, F. L., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.161299 · Cited by 427
Self-citationPienta, K. J., Gorin, M. A., Rowe, S. P., Carroll, P. R., Pouliot, F., Probst, S., Saperstein, L., Preston, M. A., Alva, A. S., Patnaik, A., et al. (2021) · Journal of Urology · doi:10.1097/ju.0000000000001698 · Cited by 398
Self-citationMorris, M. J., Rowe, S. P., Gorin, M. A., Saperstein, L., Pouliot, F., Josephson, D., Wong, J. Y. C., Pantel, A. R., Cho, S. Y., Gage, K. L., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4573 · Cited by 389
Self-citationChen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Mannweiler, S., Amersdorfer, P., Trajanoski, S., Terrett, J. A., King, D., & Mehes, G. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-008-9104-2 · Cited by 384
Eder, M., Neels, O., Müller, M., Bauder-Wüst, U., Remde, Y., Schäfer, M., Hennrich, U., Eisenhut, M., Afshar-Oromieh, A., Haberkorn, U., et al. (2014) · Pharmaceuticals · doi:10.3390/ph7070779 · Cited by 370
Self-citationE-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Ceci, F., Oprea-Lager, D. E., Emmett, L., Adam, J. A., Bomanji, J., Czernin, J., Eiber, M., Haberkorn, U., Hofman, M. S., Hope, T. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05245-y · Cited by 368
Self-citationHope, T. A., Eiber, M., Armstrong, W. R., Juarez, R., Murthy, V., Lawhn-Heath, C., Behr, S. C., Zhang, L., Barbato, F., Ceci, F., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.3771 · Cited by 357
Self-citationHan, S., Woo, S., Kim, Y. J., & Suh, C. H. (2018) · European Urology · doi:10.1016/j.eururo.2018.03.030 · Cited by 331
Sheikhbahaei, S., Afshar-Oromieh, A., Eiber, M., Solnes, L. B., Javadi, M. S., Ross, A. E., Pienta, K. J., Allaf, M. E., Haberkorn, U., Pomper, M. G., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3780-7 · Cited by 295
Self-citationViolet, J., Sandhu, S., Iravani, A., Ferdinandus, J., Thang, S.-P., Kong, G., Kumar, A. R., Akhurst, T., Pattison, D., Beaulieu, A., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.236414 · Cited by 292
Cho, S. Y., Gage, K. L., Mease, R. C., Senthamizhchelvan, S., Holt, D. P., Jeffrey-Kwanisai, A., Endres, C. J., Dannals, R. F., Sgouros, G., Lodge, M., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.104661 · Cited by 279
Self-citationGafita, A., Calais, J., Grogan, T. R., Hadaschik, B., Wang, H., Weber, M., Sandhu, S., Kratochwil, C., Esfandiari, R., Tauber, R., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00274-6 · Cited by 271
Self-citationFendler, W. P., Weber, M., Iravani, A., Hofman, M. S., Calais, J., Czernin, J., Ilhan, H., Saad, F., Small, E. J., Smith, M. R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1050 · Cited by 266
Self-citationThe Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
Terry, S., & Beltran, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00060 · Cited by 238
Rauscher, I., Krönke, M., König, M., Gafita, A., Maurer, T., Horn, T., Schiller, K., Weber, W., & Eiber, M. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.229187 · Cited by 232
Self-citationChallenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Beltran, H., Tagawa, S. T., Park, K., MacDonald, T., Milowsky, M. I., Mosquera, J. M., Rubin, M. A., & Nanus, D. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5166 · Cited by 229
Emmett, L., Yin, C., Crumbaker, M., Hruby, G., Kneebone, A., Epstein, R., Nguyen, Q., Hickey, A., Ihsheish, N., O’Neill, G., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.223099 · Cited by 223
Gafita, A., Rauscher, I., Weber, M., Hadaschik, B. A., Wang, H., Armstrong, W. R., Tauber, R., Grogan, T., Czernin, J. G., Rettig, M. B., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263072 · Cited by 221
Self-citationPSMA Ligands for PET Imaging of Prostate Cancer
Schwarzenboeck, S. M., Rauscher, I., Bluemel, C., Fendler, W. P., Rowe, S. P., Pomper, M. G., Asfhar-Oromieh, A., Herrmann, K., & Eiber, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.191031 · Cited by 215
Self-citation68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
Hope, T. A., Truillet, C., Ehman, E. C., Afshar-Oromieh, A., Aggarwal, R., Ryan, C. J., Carroll, P. R., Small, E. J., & Evans, M. J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.181800 · Cited by 214
Self-citation68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Banerjee, S. R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Green, G., Fox, J. J., Horti, A., Mease, R. C., & Pomper, M. G. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100623e · Cited by 213
The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis.
Emmett, L., Papa, N. P., Buteau, J. P., Ho, B., Liu, V., Roberts, M. J., Thompson, J. E., MOON, D. A., Sheehan‐Dare, G., Alghazo, O., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263448 · Cited by 209
Self-citation68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Rauscher, I., Maurer, T., Fendler, W. P., Sommer, W. H., Schwaiger, M., & Eiber, M. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0072-6 · Cited by 208
Self-citationOptimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
Trabulsi, E. J., Rumble, R. B., Jadvar, H., Hope, T., Pomper, M., Turkbey, B., Rosenkrantz, A. B., Verma, S., Margolis, D. J., Froemming, A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02757 · Cited by 186
Self-citationKrohn, T., Verburg, F. A., Pufe, T., Neuhuber, W., Vogg, A., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2915-3 · Cited by 180
Self-citationGiesel, F. L., Will, L., Lawal, I., Lengana, T., Kratochwil, C., Vorster, M., Neels, O., Reyneke, F., Haberkon, U., Kopka, K., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.204669 · Cited by 179
Self-citationAppropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
Jadvar, H., Calais, J., Fanti, S., Feng, F. Y.-C., Greene, K. L., Gulley, J. L., Hofman, M. S., Koontz, B. F., Lin, D. W., Morris, M. J., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263262 · Cited by 171
Self-citationRowe, S. P., Pienta, K. J., Pomper, M. G., & Gorin, M. A. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195255 · Cited by 170
Self-citationFanti, S., Hadaschik, B., & Herrmann, K. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.233817 · Cited by 165
Self-citationFreitag, M. T., Radtke, J. P., Afshar-Oromieh, A., Roethke, M. C., Hadaschik, B. A., Gleave, M., Bonekamp, D., Kopka, K., Eder, M., Heusser, T., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3594-z · Cited by 163
Self-citationAfshar-Oromieh, A., Debus, N., Uhrig, M., Hope, T. A., Evans, M. J., Holland-Letz, T., Giesel, F. L., Kopka, K., Hadaschik, B., Kratochwil, C., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4079-z · Cited by 162
Self-citationFeasibility of state of the art PET/CT systems performance harmonisation
Kaalep, A., Sera, T., Rijnsdorp, S., Yaqub, M., Talsma, A., Lodge, M. A., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3977-4 · Cited by 160
Grünig, H., Maurer, A. B., Thali, Y. A., Kovacs, Z., Strobel, K., Burger, I. A., & Müller, J. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05424-x · Cited by 158
Seitz, A. K., Rauscher, I., Haller, B., Kroenke, M., Luther, S., Heck, M. M., Horn, T. D., Gschwend, J. E., Schwaiger, M., Eiber, M. J., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3887-x · Cited by 151
Self-citationHerrmann, K., Bluemel, C., Weineisen, M., Schottelius, M., Wester, H., Czernin, J. G., Eberlein, U., Beykan, S., Lapa, C., Riedmiller, H. N., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.156133 · Cited by 148
Self-citation68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
Demirci, E., Ocak, M., Kabasakal, L., Decristoforo, C., Talat, Z., Halaç, M., & Kanmaz, B. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2766-y · Cited by 140
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
Verburg, F. A., Krohn, T., Heinzel, A., Mottaghy, F. M., & Behrendt, F. F. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3065-y · Cited by 132
Self-citationCardinale, J., Martin, R., Remde, Y., Schäfer, M. K.-H., Hienzsch, A., Hübner, S., Zerges, A.-M., Marx, H., Hesse, R., Weber, K., et al. (2017) · Pharmaceuticals · doi:10.3390/ph10040077 · Cited by 132
Self-citationMichalski, K., Ruf, J., Goetz, C., Seitz, A. K., Buck, A. K., Lapa, C., & Hartrampf, P. E. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05160-8 · Cited by 131
Aggarwal, R. R., Wei, X. X., Kim, W. B., Small, E. J., Ryan, C. J., Carroll, P. R., Cooperberg, M. R., Evans, M. J., & Hope, T. A. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.03.010 · Cited by 129
Self-citationRischpler, C., Beck, T. I., Okamoto, S., Schlitter, A. M., Knorr, K., Schwaiger, M., Gschwend, J. E., Maurer, T., Meyer, P. T., & Eiber, M. J. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.204677 · Cited by 128
Self-citationHofman, M. S., Murphy, D. G., Williams, S., Nzenza, T. C., Herschtal, A., Lourenço, R. D. A., Bailey, D. L., Budd, R., Hicks, R. J., Francis, R. J., et al. (2018) · British Journal of Urology · doi:10.1111/bju.14374 · Cited by 124
Fendler, W. P., Ferdinandus, J., Czernin, J. G., Eiber, M., Flavell, R. R., Behr, S. C., Wu, I.-W. K., Lawhn-Heath, C. A., Pampaloni, M. H., Reiter, R. E., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.242180 · Cited by 123
Self-citationUncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
Nguyen, T. A., Kirsch, B. J., Asaka, R., Nabi, K., Quinones, A., Tan, J., Antonio, M. J., Camelo, F., Li, T., Nguyen, S. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.036 · Cited by 117
Fanti, S., Minozzi, S., Morigi, J. J., Giesel, F., Ceci, F., Uprimny, C., Hofman, M. S., Eiber, M., Schwarzenbock, S., Castellucci, P., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3725-1 · Cited by 113
Self-citationSheikhbahaei, S., Werner, R. A., Sólnes, L. B., Pienta, K. J., Pomper, M. G., Gorin, M. A., & Rowe, S. P. (2019) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.02.006 · Cited by 113
Self-citationSummary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
Graham, M. M., Wahl, R. L., Hoffman, J. M., Yap, J. T., Sunderland, J. J., Boellaard, R., Perlman, E. S., Kinahan, P. E., Christian, P. E., Hoekstra, O. S., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158402 · Cited by 104
Sawicki, L. M., Buchbender, C., Boos, J., Giessing, M., Ermert, J., Antke, C., Antoch, G., & Hautzel, H. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3360-2 · Cited by 104
Rüschoff, J. H., Ferraro, D. A., Muehlematter, U. J., Laudicella, R., Hermanns, T., Rodewald, A., Moch, H., Eberli, D., Burger, I. A., & Rupp, N. J. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05501-1 · Cited by 103
Gafita, A., Rauscher, I., Fendler, W. P., Murthy, V., Wang, H., Armstrong, W. R., Herrmann, K., Weber, W., Calais, J., Eiber, M., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05882-x · Cited by 102
Self-citationFerraro, D. A., Rüschoff, J. H., Muehlematter, U. J., Kranzbühler, B., Müller, J., Messerli, M., Husmann, L., Hermanns, T., Eberli, D., Rupp, N. J., et al. (2020) · Theranostics · doi:10.7150/thno.44584 · Cited by 95
Lückerath, K., Liu, W., Fendler, W. P., Axelsson, S. E., Stuparu, A. D., Slavik, R., Mona, C. E., Calais, J., Rettig, M. B., Reiter, R. E., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0451-z · Cited by 93
Self-citationPattison, D. A., Debowski, M., Gulhane, B., Arnfield, E. G., Pelecanos, A. M., Garcia, P. L., Latter, M. J., Lin, C. Y., Roberts, M. J., Ramsay, S. C., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05520-y · Cited by 93
Ferraro, D. A., Becker, A. S., Kranzbühler, B., Mebert, I., Baltensperger, A., Zeimpekis, K., Grünig, H., Messerli, M., Rupp, N. J., Rueschoff, J. H., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05261-y · Cited by 93
Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
Arnfield, E. G., Thomas, P. A., Roberts, M. J., Pelecanos, A. M., Ramsay, S. C., Lin, C. Y., Latter, M. J., Garcia, P. L., & Pattison, D. A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05456-3 · Cited by 89
Kramer, V., Fernández, R., Lehnert, W., Jiménez‐Franco, L. D., Soza‐Ried, C., Eppard, E., Ceballos, M., Meckel, M., Benešová, M., Umbricht, C. A., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05022-3 · Cited by 80
John, N., Pathmanandavel, S., Crumbaker, M., Counter, W., Ho, B., Yam, A. O. W., Wilson, P., Niman, R., Ayers, M., Poole, A., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264677 · Cited by 80
Quantitative implications of the updated EARL 2019 PET–CT performance standards
Kaalep, A., Burggraaff, C. N., Pieplenbosch, S., Verwer, E. E., Sera, T., Zijlstra, J., Hoekstra, O. S., Oprea-Lager, D. E., & Boellaard, R. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0257-8 · Cited by 79
Self-citationWang, B., Liu, C., Yu, W., Meng, J., Zhang, Y., Gan, H., Xu, X., Wan, F., Pan, J. G., Ma, X., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0587 · Cited by 73
Sheehan, B., Guo, C. W., Neeb, A., Paschalis, A., Sandhu, S. K., & Bono, J. S. D. (2021) · European Urology Focus · doi:10.1016/j.euf.2021.06.006 · Cited by 73
Yao, V., & Bacich, D. J. (2006) · The Prostate · doi:10.1002/pros.20361 · Cited by 72
Hotta, M., Gafita, A., Czernin, J. G., & Calais, J. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263441 · Cited by 70
Self-citationGrubmüller, B., Rasul, S., Baltzer, P., Fajković, H., D’Andrea, D., Berndl, F., Maj‐Hes, A., Grubmüller, K. H., Mitterhauser, M., Wadsak, W., et al. (2019) · The Prostate · doi:10.1002/pros.23919 · Cited by 69
Rathke, H. G., Holland‐Letz, T., Mier, W., Flechsig, P., Mavriopoulou, E., Röhrich, M., Kopka, K., Hohenfellner, M., Giesel, F. L., Haberkorn, U., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.231431 · Cited by 68
Self-citationAhmadzadehfar, H., Azgomi, K., Hauser, S., Wei, X. X., Yordanova, A., Gaertner, F. C., Kürpig, S., Strunk, H. M., & Essler, M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178533 · Cited by 59
Schmidkonz, C., Cordes, M., Goetz, T. I., Prante, O., Kuwert, T., Ritt, P., Uder, M., Wullich, B., Goebell, P. J., & Bäuerle, T. (2019) · Annals of Nuclear Medicine · doi:10.1007/s12149-019-01387-0 · Cited by 59
Werner, R. A., Bundschuh, R. A., Bundschuh, L., Javadi, M. S., Leal, J. P., Higuchi, T., Pienta, K. J., Buck, A. K., Pomper, M. G., Gorin, M. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217588 · Cited by 55
Self-citationOh, S. W., Wurzer, A. J., Teoh, E., Oh, S., Langbein, T., Kroenke, M., Herz, M., Kropf, S., Wester, H., Weber, W., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.234609 · Cited by 53
Self-citationZukotynski, K., Emmenegger, U., Hotte, S. J., Kapoor, A., Fu, W., Blackford, A. L., Valliant, J. F., Bénard, F., Kim, C. K., Markowski, M. C., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259069 · Cited by 52
Self-citationSafety, Biodistribution, and Radiation Dosimetry of 18F-rhPSMA-7.3 in Healthy Adult Volunteers
Tolvanen, T., Kalliokoski, K. K., Malaspina, S., Kuisma, A., Lahdenpohja, S., Postema, E. J., Miller, M. P., & Scheinin, M. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.252114 · Cited by 50
Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
Michalski, K., Klein, C., Brüggemann, T., Meyer, P. T., Jilg, C. A., & Ruf, J. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.260836 · Cited by 50
Yin, Y., Werner, R. A., Higuchi, T., Lapa, C., Pienta, K. J., Pomper, M. G., Gorin, M. A., & Rowe, S. P. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217653 · Cited by 49
Self-citationGüler, O. C., Engels, B., Önal, C., Everaert, H., den Begin, R. V., Gevaert, T., & Ridder, M. D. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1736-9 · Cited by 47
Plouznikoff, N., Artigas, C., Sideris, S., Chanzá, N. M., Gil, T., Peltier, A., & Flamen, P. (2019) · Annals of Nuclear Medicine · doi:10.1007/s12149-019-01404-2 · Cited by 47
Clinical utility of gallium-68 PSMA PET/CT scan for prostate cancer
Kallur, K., Ramachandra, P., Rajkumar, K., Swamy, S., Desai, I., Rao, R., Patil, S., Sridhar, P., Madhusudhan, N., Krishnappa, R., et al. (2017) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.202255 · Cited by 45
Önal, C., Güler, O. C., Torun, N., Reyhan, M., & Yapar, A. F. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04581-4 · Cited by 45
Fourquet, A., Aveline, C., Cussenot, O., Créhange, G., Montravers, F., Talbot, J., & Gauthé, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58975-8 · Cited by 45
Werner, R. A., Sheikhbahaei, S., Jones, K. M., Javadi, M. S., Sólnes, L. B., Ross, A. E., Allaf, M. E., Pienta, K. J., Lapa, C., Buck, A. K., et al. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1201-4 · Cited by 44
Self-citationHürmüz, P., Önal, C., Özyiğit, G., İğdem, Ş., Atalar, B., Sayan, H., Akgün, Z., Kurt, M., Ozkok, H. B., Selek, U., et al. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01660-6 · Cited by 43
Farolfi, A., Gafita, A., Calais, J., Eiber, M., Afshar‐Oromieh, A., Spohn, F., Barbato, F., Weber, M., Ilhan, H., Cervati, V., et al. (2019) · The Journal of Urology · doi:10.1097/ju.0000000000000417 · Cited by 42
Self-citationWondergem, M., van der Zant, F. M., Broos, W. A. M., & Knol, R. J. J. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.258574 · Cited by 41
68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients
Zang, S., Shao, G., Cui, C., Li, T., Huang, Y., Yao, X., Fan, Q., Chen, Z., Du, J., Jia, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14691 · Cited by 36
Bianchi, L., Castellucci, P., Farolfi, A., Droghetti, M., Artigas, C., Leite, J., Corona, P., Shagera, Q. A., Moreira, R., González, C. J., et al. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.12.002 · Cited by 36
Self-citationPSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
Weber, M., Kurek, C., Barbato, F., Eiber, M., Maurer, T., Nader, M., Hadaschik, B. A., Grünwald, V., Herrmann, K., Wetter, A., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.245456 · Cited by 35
Self-citationStrategies for Implementing a Standardized Structured Radiology Reporting Program
Larson, D. B. (2018) · Radiographics · doi:10.1148/rg.2018180040 · Cited by 33
The VISION Forward: Recognition and Implication of PSMA−/18F-FDG+ mCRPC
Jadvar, H. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263274 · Cited by 33
Multicentre quantitative 68Ga PET/CT performance harmonisation
de Vries–Huizing, D. M. V., Koopman, D., van Dalen, J. A., Gotthardt, M., Boellaard, R., Séra, T., Sinaasappel, M., Stokkel, M. P. M., & der Veen, B. J. D. W. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0253-z · Cited by 31
Farolfi, A., Hirmas, N., Gafita, A., Weber, M., Barbato, F., Wetter, A., Mei, R., Pianori, D., Hadaschik, B. A., Herrmann, K., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.246603 · Cited by 28
Self-citationCalais, J., Zhu, S., Hirmas, N., Eiber, M., Hadaschik, B. A., Stuschke, M., Herrmann, K., Czernin, J. G., Kishan, A. U., Nickols, N. G., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08026-w · Cited by 27
Self-citationFerraro, D. A., Laudicella, R., Zeimpekis, K., Mebert, I., Müller, J., Maurer, A. B., Grünig, H., Donati, O. F., Sapienza, M. T., Rueschoff, J. H., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05599-3 · Cited by 27
Improved 223Ra Therapy with Combination Epithelial Sodium Channel Blockade
Abou, D. S., Fears, A., Summer, L., Longtine, M. S., Benabdallah, N., Riddle, R. C., Ulmert, D., Michalski, J. M., Wahl, R. L., Chesner, D., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.261977 · Cited by 13
Optimization of injected 68Ga-PSMA activity based on list-mode phantom data and clinical validation
Wielaard, J., Habraken, J. B. A., Brinks, P., Lavalaye, J., & Boellaard, R. (2020) · EJNMMI Physics · doi:10.1186/s40658-020-00289-9 · Cited by 9
Pattison, D. A., Debowski, M., Gulhane, B., Arnfield, E. G., Pelecanos, A. M., Garcia, P. L., Latter, M. J., Lin, C. Y., Roberts, M. J., Ramsay, S. C., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05548-0 · Cited by 5
Cited by
Dorff, T., Horvath, L. G., Autio, K., Bernard-Tessier, A., Rettig, M. B., Machiels, J.-P., Bilen, M. A., Lolkema, M. P., Adra, N., Rottey, S., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2978 · Cited by 76
Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands
Naik, M., Khan, S. R., Lewington, V., Challapalli, A., Eccles, A., & Barwick, T. D. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae092 · Cited by 10
Metadata
- Authors
- Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Calais, J., Ceci, F., Cho, S. Y., Fanti, S., Giesel, F. L., Goffin, K., Haberkorn, U., Jacene, H., Koo, P. J., Kopka, K., Krause, B. J., Lindenberg, L., Marcus, C., Mottaghy, F. M., Oprea-Lager, D. E., Osborne, J. R., Piert, M., Rowe, S. P., Schöder, H., Wan, S., Wester, H.-J., Hope, T. A., & Herrmann, K.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2023-01-05
- Volume
- 50
- Issue
- 5
- Pages
- 1466-1486
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W4313549642
- Cited by
- 410
- References
- 129
- FWCI
- 60.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.